Earnings Call · Q2 FY2025·2025-08-07

Q2 25EPS +25.93%·Rev n/aQ1 25EPS +32.35%·Rev n/aQ4 24EPS +37.50%·Rev n/aQ3 24EPS +11.76%·Rev n/a⚠ consensus missing

CATALYST PHARMACEUTICALS, INC. CPRX

Michael W. Kalb — Chief Financial Officer

Richard John Daly — President and Chief Executive Officer

Jeffrey Del Carmen — Chief Commercial Officer

−1.9%1d on move date−2.7% vs SPY3d−10.6%5d−8.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CPRX calls or request research access.

More CPRX calls Browse calls Request research access